CA2736117C — Compounds, compositions and methods of using same for modulating uric acid levels
Assigned to Ardea Biociences Inc · Expires 2013-11-19 · 12y expired
What this patent protects
Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of making and using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant level…
USPTO Abstract
Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of making and using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid, such as gout or hyperuricemia. ( see above formula)
Drugs covered by this patent
- Zurampic (LESINURAD) · Ironwood Pharms Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.